Complexo Hospitalario Universitario A Coruña

2014

1. "Doctora no se me acerque que le saltan bichos"

   Cadernos de atención primaria, Vol. 20, Núm. 2, pp. 98-100

2. "very early" intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?

   American Journal of Transplantation, Vol. 14, Núm. 3, pp. 660-667

3. 10th congress on lung cancer-Updates on clinical trials: Goal

   Translational Lung Cancer Research, Vol. 3, Núm. 2, pp. 66-69

4. 2-(dimethylamino)ethyl methacrylate/(2-hydroxyethyl) methacrylate/α-tricalcium phosphate cryogels for bone repair, preparation and evaluation of the biological response of human trabecular bone-derived cells and mesenchymal stem cells

   Polymers, Vol. 6, Núm. 10, pp. 2510-2525

5. A Polymorphism in the Promoter Region of the Survivin Gene is Related to Hemorrhagic Transformation in Patients with Acute Ischemic Stroke

   NeuroMolecular Medicine, Vol. 16, Núm. 4, pp. 856-861

6. A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice

   Molecular Cancer, Vol. 13, Núm. 1

7. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

   Arthritis Research and Therapy, Vol. 16, Núm. 1

8. A hidden cause of virilization in postmenopausal women

   Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 61, Núm. 8, pp. 436-438

9. A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems

   Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 3, pp. 682-690

10. A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 12, pp. 2130-2136

11. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    European Heart Journal, Vol. 35, Núm. 30, pp. 2010-2020

12. A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine

    Scientific Reports, Vol. 4

13. A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): A Galician Lung Cancer Group (GGCP) study

    Cancer Chemotherapy and Pharmacology, Vol. 73, Núm. 3, pp. 451-457

14. A randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia

    International Journal of Clinical Practice, Vol. 68, Núm. 10, pp. 1231-1238

15. Accurate identification of ALK positive lung carcinoma patients: Novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

    PLoS ONE, Vol. 9, Núm. 9

16. Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: Challenges and lessons learned

    American Journal of Hypertension, Vol. 27, Núm. 8, pp. 1052-1060

17. Acroqueratosis de Bazex como síndrome paraneoplásico

    Acta Otorrinolaringologica Espanola, Vol. 65, Núm. 2, pp. 138-139

18. Adipokines as drug targets in joint and bone disease

    Drug Discovery Today, Vol. 19, Núm. 3, pp. 241-258

19. Adipokines, metabolic syndrome and rheumatic diseases

    Journal of Immunology Research, Vol. 2014

20. Adiponectin and leptin: New targets in inflammation

    Basic and Clinical Pharmacology and Toxicology, Vol. 114, Núm. 1, pp. 97-102